ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 142 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $325,036 | -69.2% | 219,462 | -66.5% | 0.00% | – |
| Q2 2023 | $1,055,905 | -74.6% | 655,773 | -54.2% | 0.00% | -100.0% |
| Q1 2023 | $4,152,878 | +142512.6% | 1,432,142 | +61.2% | 0.00% | 0.0% |
| Q4 2022 | $2,912 | -99.9% | 888,165 | +44.0% | 0.00% | 0.0% |
| Q3 2022 | $2,332,000 | -73.8% | 616,968 | -46.1% | 0.00% | -66.7% |
| Q2 2022 | $8,917,000 | -28.4% | 1,144,956 | -14.6% | 0.00% | -25.0% |
| Q1 2022 | $12,451,000 | -35.5% | 1,340,251 | +9.5% | 0.00% | -33.3% |
| Q4 2021 | $19,299,000 | +18.4% | 1,224,510 | +34.4% | 0.01% | +20.0% |
| Q3 2021 | $16,305,000 | -21.8% | 910,928 | -32.1% | 0.01% | -28.6% |
| Q2 2021 | $20,848,000 | +19.2% | 1,340,745 | +10.3% | 0.01% | +16.7% |
| Q1 2021 | $17,486,000 | -1.6% | 1,216,052 | +34.3% | 0.01% | 0.0% |
| Q4 2020 | $17,775,000 | +64.9% | 905,344 | +8.8% | 0.01% | +20.0% |
| Q3 2020 | $10,781,000 | -8.1% | 831,882 | +3.3% | 0.01% | 0.0% |
| Q2 2020 | $11,732,000 | +91.6% | 805,384 | +12.0% | 0.01% | +66.7% |
| Q1 2020 | $6,122,000 | -40.6% | 719,382 | +14.9% | 0.00% | -25.0% |
| Q4 2019 | $10,312,000 | +32.8% | 626,144 | +13.9% | 0.00% | +33.3% |
| Q3 2019 | $7,763,000 | -18.3% | 549,851 | +16.3% | 0.00% | -25.0% |
| Q2 2019 | $9,505,000 | -49.9% | 472,655 | -1.0% | 0.00% | -50.0% |
| Q1 2019 | $18,981,000 | +15.0% | 477,551 | +0.5% | 0.01% | +14.3% |
| Q4 2018 | $16,500,000 | +74.2% | 474,973 | +107.3% | 0.01% | +75.0% |
| Q3 2018 | $9,474,000 | +2038.6% | 229,141 | +1801.1% | 0.00% | – |
| Q2 2018 | $443,000 | -48.3% | 12,053 | -45.1% | 0.00% | – |
| Q1 2018 | $857,000 | +108.0% | 21,971 | -3.5% | 0.00% | – |
| Q4 2017 | $412,000 | +9.3% | 22,771 | 0.0% | 0.00% | – |
| Q3 2017 | $377,000 | +24.0% | 22,771 | +4.8% | 0.00% | – |
| Q2 2017 | $304,000 | -30.0% | 21,718 | +2.9% | 0.00% | – |
| Q1 2017 | $434,000 | +40.0% | 21,108 | -3.2% | 0.00% | – |
| Q4 2016 | $310,000 | -8.8% | 21,797 | +37.0% | 0.00% | – |
| Q3 2016 | $340,000 | – | 15,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,576,000 | 23.33% |
| Antipodean Advisors LLC | 1,000,000 | $15,760,000 | 6.47% |
| M28 Capital Management LP | 456,865 | $7,200,000 | 5.62% |
| Redmile Group, LLC | 6,437,777 | $101,459,000 | 2.31% |
| One Fin Capital Management LP | 303,000 | $4,775,000 | 1.99% |
| MAVERICK CAPITAL LTD | 7,855,824 | $123,808,000 | 1.40% |
| Baupost Group | 8,477,488 | $133,605,000 | 1.32% |
| BRIDGER MANAGEMENT, LLC | 616,488 | $9,716,000 | 1.26% |
| 683 Capital Management, LLC | 1,781,234 | $28,073,000 | 1.03% |
| Trellus Management Company, LLC | 95,000 | $1,497,000 | 1.00% |